Your browser doesn't support javascript.
loading
A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity.
Kallen, E J J; Revers, A; Fernández-Rivas, M; Asero, R; Ballmer-Weber, B; Barreales, L; Belohlavkova, S; de Blay, F; Clausen, M; Dubakiene, R; Ebisawa, M; Fernández-Perez, C; Fritsche, P; Fukutomi, Y; Gislason, D; Hoffmann-Sommergruber, K; Jedrzejczak-Czechowicz, M; Knulst, A C; Kowalski, M L; Kralimarkova, T; Lidholm, J; Metzler, C; Mills, E N C; Papadopoulos, N G; Popov, T A; Purohit, A; Reig, I; Seneviratne, S L; Sinaniotis, A; Takei, M; Versteeg, S A; Vassilopoulou, A E; Vieths, S; Welsing, P M J; Zwinderman, A H; Le, T M; Van Ree, R.
Afiliación
  • Kallen EJJ; Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Revers A; Epidemiology and Data Science (EDS), Amsterdam University Medical Center location University of Amsterdam, Amsterdam, The Netherlands.
  • Fernández-Rivas M; Department of Allergy, Hospital Clinico San Carlos, Universidad Complutense, IdISSC, ARADyAL, Madrid, Spain.
  • Asero R; Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy.
  • Ballmer-Weber B; Allergy Unit, Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
  • Barreales L; Faculty of Medicine, University of Zürich, Zürich, Switzerland.
  • Belohlavkova S; Clinic for Dermatology and Allergology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • de Blay F; Department of Allergy, Hospital Clinico San Carlos, Universidad Complutense, IdISSC, ARADyAL, Madrid, Spain.
  • Clausen M; Medical Faculty Pilsen, Charles University Prague, Prague, Czech Republic.
  • Dubakiene R; Allergy Division, Chest Disease Department, Strasbourg University Hospital, Strasbourg, France.
  • Ebisawa M; Landspitali University Hospital, University of Iceland, Faculty of Medicine, Reykjavik, Iceland.
  • Fernández-Perez C; Clinic of Chest diseases, Allergology and Immunology Institute of Clinic al Medicine Medical Faculty Vilnius University, Vilnius, Lithuania.
  • Fritsche P; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
  • Fukutomi Y; Servicio de Medicina Preventiva, Area De Santiago de Compostela y Barbanza, Instituto de Investigación Sanitaria de Santiago (IDIS) A Coruña, Santiago, Spain.
  • Gislason D; Allergy Unit, Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
  • Hoffmann-Sommergruber K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
  • Jedrzejczak-Czechowicz M; Landspitali University Hospital, University of Iceland, Faculty of Medicine, Reykjavik, Iceland.
  • Knulst AC; Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
  • Kowalski ML; Department of Immunology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
  • Kralimarkova T; Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Lidholm J; Department of Immunology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
  • Metzler C; Clinic of Occupational Diseases, University Hospital Sv. Ivan Rilski, Sofia, Bulgaria.
  • Mills ENC; Thermo Fisher Scientific, Uppsala, Sweden.
  • Papadopoulos NG; Allergy Unit, Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
  • Popov TA; Division of Infection, Immunity and Respiratory Medicine, Manchester Institute of Biotechnology & Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
  • Purohit A; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Reig I; Clinic of Occupational Diseases, University Hospital Sv. Ivan Rilski, Sofia, Bulgaria.
  • Seneviratne SL; Allergy Division, Chest Disease Department, Strasbourg University Hospital, Strasbourg, France.
  • Sinaniotis A; Allergist and Pediatrician, Nápoles y Sicilia Health Center, Valencia, Spain.
  • Takei M; Institute of Immunity and Transplantation, University College London, London, UK.
  • Versteeg SA; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Vassilopoulou AE; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
  • Vieths S; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Welsing PMJ; Department of Nutritional Sciences and Dietetics, International Hellenic University, Thessaloniki, Greece.
  • Zwinderman AH; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
  • Le TM; Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Van Ree R; Epidemiology and Data Science (EDS), Amsterdam University Medical Center location University of Amsterdam, Amsterdam, The Netherlands.
Allergy ; 78(9): 2497-2509, 2023 09.
Article en En | MEDLINE | ID: mdl-37334557
ABSTRACT

BACKGROUND:

Pru p 3 and Pru p 7 have been implicated as risk factors for severe peach allergy. This study aimed to establish sensitization patterns to five peach components across Europe and in Japan, to explore their relation to pollen and foods and to predict symptom severity.

METHODS:

In twelve European (EuroPrevall project) and one Japanese outpatient clinic, a standardized clinical evaluation was conducted in 1231 patients who reported symptoms to peach and/or were sensitized to peach. Specific IgE against Pru p 1, 2, 3, 4 and 7 and against Cup s 7 was measured in 474 of them. Univariable and multivariable Lasso regression was applied to identify combinations of parameters predicting severity.

RESULTS:

Sensitization to Pru p 3 dominated in Southern Europe but was also quite common in Northern and Central Europe. Sensitization to Pru p 7 was low and variable in the European centers but very dominant in Japan. Severity could be predicted by a model combining age of onset of peach allergy, probable mugwort, Parietaria pollen and latex allergy, and sensitization to Japanese cedar pollen, Pru p 4 and Pru p 7 which resulted in an AUC of 0.73 (95% CI 0.73-0.74). Pru p 3 tended to be a risk factor in South Europe only.

CONCLUSIONS:

Pru p 7 was confirmed as a significant risk factor for severe peach allergy in Europe and Japan. Combining outcomes from clinical and demographic background with serology resulted in a model that could better predict severity than CRD alone.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prunus persica / Hipersensibilidad a los Alimentos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Allergy Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prunus persica / Hipersensibilidad a los Alimentos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Allergy Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos